about
Clinical management of regorafenib in the treatment of patients with advanced colorectal cancerPreventive treatments for breast cancer: recent developmentsThe relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma.Genetic alterations in chronic lymphocytic leukaemiaTesticular cancer in androgen insensitivity syndrome in a Mexican populationRole of CHK2 in cancer developmentRole of TIM-3 in ovarian cancer.Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2V617F mutations and laboratory findings: a meta-analysis.A consensus statement on the gender perspective in lung cancer.Survival in glioblastoma: a review on the impact of treatment modalities.Intimal-medial thickness and carotid arteries lumen in irradiated patients for head and neck cancer: preliminary data of an observational study.Selecting housekeeping genes as references for the normalization of quantitative PCR data in breast cancer.Safety and efficacy of first-line bevacizumab combination therapy in Chinese population with advanced non-squamous NSCLC: data of subgroup analyses from MO19390 (SAiL) study.Synchronous versus metachronous brain metastasis from testicular germ cell tumors (TGCT): an analysis from the Spanish Germ Cell Cancer Group data base.A new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products.Doublet BRAF/MEK inhibition versus single-agent BRAF inhibition in the management of BRAF-mutant advanced melanoma, biological rationale and meta-analysis of published data.Cancer epidemiology: study designs and data analysis.Looking for complementary alternatives to CTCAE for skin toxicity in radiotherapy: quantitative determinations.High throughput screening in drug discovery.Contributions of advanced proteomics technologies to cancer diagnosis.Metastatic disease from chordoma.Sacral chordoma: management of a rare disease in a tertiary hospital.Combinatorial chemistry in cancer research.Biochemotherapy with low doses of subcutaneous interleukin-2 in patients with melanoma: results of a phase II trial.Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.Low dose gemcitabine plus cisplatin in a weekly-based regimen as salvage therapy for relapsed breast cancer after taxane-anthracycline-containing regimens.Biochemotherapy in the treatment of metastatic melanoma in selected patients.Haemolytic uraemic syndrome associated with gemcitabine.Limited impact of palliative chemotherapy on survival in advanced solid tumours in patients with poor performance status.Primary pineal tumors: outcome and prognostic factors--a study from the Rare Cancer Network (RCN).Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients.Outcome and toxicity using helical tomotherapy for craniospinal irradiation in pediatric medulloblastoma.Gemcitabine plus capecitabine (Gem-Cape) biweekly in chemorefractory metastatic colorectal cancer.GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and poor performance status.Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer.Clinical behavior of solitary fibrous tumor: a retrospective review of 30 patients.Response to erlotinib in recurrent glioblastoma multiforme showing coexpression of EGFRvIII and PTEN.Evidence-based consensus recommendations to improve the quality of life in prostate cancer treatment.Tracheal chondrosarcoma.Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.
P1433
Q26821956-E2BF3F0D-3E43-4759-A710-FA2E823F46EDQ27025375-2570FF73-D071-4172-B7DA-16C21B7C5CE5Q27853223-94DAC7A6-CB70-482C-94B0-8D8DACC3DC26Q28241911-51F1DCBA-CDEE-4EBD-8A71-CEDC3E1DDAF4Q28303409-D0324029-131B-4955-BFB8-CF34BE751A76Q28611402-874334F6-30AA-40C5-B078-6619C21C3BE3Q30235023-C2863EC2-1AF0-4718-97CC-E41B27D2D7CEQ30235926-265BBF19-7A66-45B0-86D0-F4D38C800ACAQ30240700-D96C7954-80A9-443E-8977-CFCC84CD6EADQ30251810-961AEF26-FED7-456A-B4E4-5F09F751AA58Q30596784-C7DDBA8D-694B-40DB-8CAD-3F7E0744E74FQ30635987-D4681548-0113-4819-830F-D54DFE63C50FQ30664849-B1FB0063-44FE-4E97-92BF-620F302A606EQ30797642-982DE09A-04D5-41CD-B1CA-ED6FF3C71A01Q30874197-E5E9D0D0-971E-46A1-9DBA-7D1720B9FE45Q31014100-DAD689DD-CF8E-4DA8-A088-0ED3B9A1E152Q31113709-7E9A3B84-4333-4B7A-8D04-2220CAFD49E8Q31154210-06E5E911-D47A-4469-913A-3F61B5D810CDQ33251878-788830CA-BDAE-4203-8318-F01DD152C816Q33256357-4C1CC612-87CF-4C99-8219-D4EC126C840EQ33273152-9EA5B158-2A78-415A-B604-72AB44EE4B4DQ33274531-EBD76432-5362-44F1-AA9C-03931439EB47Q33276094-95435992-E7E9-44BE-8E83-6BFBF7748934Q33368188-A67D4804-7698-4175-94C2-8476AC708B11Q33373132-0396DB4D-C3BF-4835-A8D9-0786452135DBQ33375974-73462B28-1F94-448A-BBBA-755FFBB11D75Q33385028-77F00B24-C131-431A-9A55-0559016E9A96Q33389539-C4677256-279D-40E6-98EA-947756265AA5Q33395825-F82FDC78-84B7-4A8C-AAA5-4E1D567B0EFFQ33402930-04D1DDEF-ECED-4A9B-A5A1-BF5CC02A8AF6Q33407274-197C88E8-BE47-4FFD-B3FC-AAC24242A885Q33407400-BB04FDE7-1BEF-4CCF-9A6B-9844AA697E7BQ33418889-ECAB9601-69DC-44F5-B113-5684B7D2A448Q33427367-AD36A582-10FE-4BB1-A99A-FB14B958A078Q33431168-386027A4-3E27-4DBF-A651-31C4A93980B9Q33435217-0EAC1E12-BF70-4474-9000-662DD10B31CDQ33576476-2639EB2B-5136-4B82-AFF0-C9424E174B8EQ33577684-9CFADA97-3364-4BC4-9F39-0A5D2A6803D8Q33658171-56E50637-941C-48C8-A4DD-8025B6759B8EQ33665450-57CE8750-3F0B-478A-8A3B-3FB05F1DBFD9
P1433
description
journal
@en
revista
@es
vědecký časopis
@cs
wetenschappelijk tijdschrift van Springer Science+Business Media
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
英语期刊
@zh
name
Clinical and Translational Oncology
@ast
Clinical and Translational Oncology
@en
Clinical and Translational Oncology
@es
Clinical and Translational Oncology
@it
Clinical and Translational Oncology
@nl
Clinical and Translational Oncology
@pt
type
label
Clinical and Translational Oncology
@ast
Clinical and Translational Oncology
@en
Clinical and Translational Oncology
@es
Clinical and Translational Oncology
@it
Clinical and Translational Oncology
@nl
Clinical and Translational Oncology
@pt
prefLabel
Clinical and Translational Oncology
@ast
Clinical and Translational Oncology
@en
Clinical and Translational Oncology
@es
Clinical and Translational Oncology
@it
Clinical and Translational Oncology
@nl
Clinical and Translational Oncology
@pt
P3181
P1055
P1058
P1156
3500148006
P1250
P1476
Clinical and Translational Oncology
@en